Cargo Therapeutics Announces Delisting from Nasdaq Following Merger Completion
I'm PortAI, I can summarize articles.
Cargo Therapeutics Inc. has announced its delisting from Nasdaq following its merger with Concentra Biosciences, LLC. The company has notified Nasdaq of the merger's completion and requested the suspension of trading of its shares, effective August 19, 2025. Additionally, Cargo Therapeutics has filed a Notification of Removal from Listing with the SEC to delist its shares and terminate its registration under the Securities Exchange Act of 1934, becoming a wholly owned subsidiary of Concentra Biosciences.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments